Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 10/20 | 0.65 |
| ▸ | LPL | P06858 | 9/20 | 0.65 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | F11 | P03951 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.36 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10071636 | 0.96 | LIPG (0.65) | LIPGLPLNPC1HPGDMAPK1 | |
| SCHEMBL16601879 | 0.93 | LPL (0.71) | LIPGLPLPTGS2CYP3A4GPR84 | |
| SCHEMBL15132542 | 0.93 | LPL (0.71) | LIPGLPLPTGS2CYP3A4GPR84 | |
| SCHEMBL29400355 | 0.90 | LPL (0.71) | LIPGLPLPTGS2CYP3A4GPR84 | |
| SCHEMBL12620510 | 0.84 | LPL (0.64) | LIPGLPLPTGS2CYP3A4GPR84 | |
| SCHEMBL14750160 | 0.83 | LIPG (0.91) | LIPGLPLF11SKP2 | |
| SCHEMBL31442702 | 0.83 | LPL (0.62) | LIPGLPLPTGS2CYP3A4 | |
| SCHEMBL13471474 | 0.82 | LIPG (0.90) | LIPGLPLF11ESR2 | |
| SCHEMBL18230458 | 0.81 | LIPG (0.52) | LIPGLPLF11ESR2 | |
| SCHEMBL31442550 | 0.80 | LPL (0.58) | LIPGLPL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11800785-B2 | Material for organic device and organic electroluminescent device using the same | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2023-10-24 | — | — | US | disclosed |
| US-20220006012-A1 | MATERIAL FOR ORGANIC DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2022-01-06 | — | — | US | disclosed |
| US-11168161-B2 | Biaryl phenoxy group IV transition metal catalysts for olefin polymerization | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-11-09 | — | — | US | disclosed |
| US-20200157254-A1 | BIARYL PHENOXY GROUP IV TRANSITION METAL CATALYSTS FOR OLEFIN POLYERMIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11800785-B2 | Material for organic device and organic electroluminescent device using the same | RER1, LEF1, CHRM1 | LIPG 3005/4885LPL 2241/4885NPC1 2280/4885 |
| US-11168161-B2 | Biaryl phenoxy group IV transition metal catalysts for olefin polymerization | PPOX, LIG4, PARG | LIPG 2258/4885LPL 2686/4885NPC1 4629/4885 |
| US-20220006012-A1 | MATERIAL FOR ORGANIC DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | RER1, LEF1, CHRM1 | LIPG 3005/4885LPL 2241/4885NPC1 2280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.